MeSH term
Frequency | Condition_Probility | Animals | 26 | 0.0 |
Cell Differentiation | 9 | 0.0 |
Cell Line | 6 | 0.0 |
Cell Survival | 2 | 0.0 |
Humans | 57 | 0.0 |
Protein Binding | 3 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 29 | 0.0 |
Trans-Activation (Genetics) | 4 | 0.0 |
Down-Regulation | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
*Genes, myc | 7 | 3.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Repressor Proteins/*physiology | 2 | 1.0 |
Research Support, Non-U.S. Gov't | 48 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
Male | 20 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 4 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Kinetics | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Transcription Factors/genetics/*metabolism | 2 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Transfection | 5 | 0.0 |
Tumor Cells, Cultured | 11 | 0.0 |
*Repressor Proteins | 19 | 1.0 |
Base Sequence | 21 | 0.0 |
Blotting, Western | 3 | 0.0 |
*Cell Transformation, Neoplastic | 2 | 0.0 |
DNA/metabolism | 5 | 0.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Dimerization | 5 | 0.0 |
Fibroblasts | 2 | 0.0 |
Gene Deletion | 3 | 0.0 |
Leucine Zippers | 5 | 3.0 |
Molecular Sequence Data | 23 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Rabbits | 2 | 0.0 |
Female | 10 | 0.0 |
Middle Aged | 9 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Cell Division/physiology | 4 | 0.0 |
Adult | 8 | 0.0 |
Aged | 8 | 0.0 |
DNA Primers | 5 | 0.0 |
Reproducibility of Results | 2 | 0.0 |
Cell Division | 6 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Gene Expression | 4 | 0.0 |
Mice | 11 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Proto-Oncogene Proteins c-myc/*antagonists & inhibitors | 2 | 50.0 |
Amino Acid Sequence | 14 | 0.0 |
COS Cells | 2 | 0.0 |
DNA, Complementary | 4 | 0.0 |
Hela Cells | 4 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Helix-Loop-Helix Motifs | 10 | 4.0 |
Models, Molecular | 2 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Chromosomes, Human, Pair 10/*genetics | 3 | 2.0 |
DNA-Binding Proteins/*genetics | 16 | 0.0 |
Loss of Heterozygosity | 5 | 0.0 |
Transcription Factors/*genetics | 11 | 0.0 |
*Tumor Suppressor Proteins | 3 | 0.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
Mutation | 4 | 0.0 |
Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
*Mutation | 3 | 0.0 |
Polymorphism, Genetic | 4 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Proto-Oncogene Proteins c-myc/*metabolism | 5 | 5.0 |
*Transcription, Genetic | 4 | 0.0 |
Genes, Tumor Suppressor | 4 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Rats | 4 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Transcription Factors/*metabolism | 3 | 0.0 |
DNA, Neoplasm/genetics | 3 | 0.0 |
Genotype | 3 | 0.0 |
Microsatellite Repeats | 4 | 0.0 |
*Chromosomes, Human, Pair 10 | 7 | 3.0 |
DNA-Binding Proteins/genetics | 4 | 0.0 |
*Genes, Tumor Suppressor | 9 | 0.0 |
Transcription Factors/genetics | 3 | 0.0 |
Translocation, Genetic | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Carcinoma, Small Cell/*genetics | 2 | 3.0 |
Lung Neoplasms/*genetics | 2 | 0.0 |
DNA, Neoplasm/analysis | 2 | 0.0 |
DNA-Binding Proteins/*genetics/physiology | 3 | 3.0 |
*Gene Deletion | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 5 | 0.0 |
Neoplasm Recurrence, Local | 2 | 0.0 |
Prostatic Neoplasms/*genetics | 2 | 1.0 |
Transcription Factors/*genetics/physiology | 2 | 2.0 |
Proto-Oncogene Proteins c-myc/*physiology | 3 | 7.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
Glioblastoma/*genetics | 2 | 2.0 |
Genes, myc | 5 | 1.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Cell Differentiation/physiology | 2 | 0.0 |
DNA-Binding Proteins/*biosynthesis/genetics | 2 | 2.0 |
*Transcription Factors | 15 | 0.0 |
Alleles | 4 | 0.0 |
Exons | 2 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Macromolecular Substances | 3 | 0.0 |
Cell Division/genetics | 2 | 0.0 |
Chromosomes, Human, Pair 10/genetics | 2 | 2.0 |
Genetic Markers | 2 | 0.0 |
DNA, Neoplasm/genetics/metabolism | 2 | 2.0 |
*Carrier Proteins | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins c-myc/genetics/*metabolism | 2 | 4.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 3 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Binding Sites | 5 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
RNA, Messenger | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Prostatic Neoplasms/*genetics/pathology | 2 | 2.0 |
Gene Expression Regulation | 2 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Chromosomes, Human, Pair 10 | 3 | 2.0 |
Comparative Study | 5 | 0.0 |
Heterozygote | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
*Gene Expression Regulation, Leukemic | 2 | 2.0 |
RNA, Messenger/analysis | 4 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 3 | 0.0 |
*Chromosomes, Human, Pair 2 | 2 | 0.0 |
In Vitro | 2 | 0.0 |
